Cellectis S.A.
CLLS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001627281
No open-market purchases or sales by Cellectis S.A. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $28.4M in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Cellectis S.A. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 45
- −6 vs. Q1 2022
- Shares held
- 10.8M
- −1.44M (−11.7%) vs. Q1 2022
- Total value
- $30.6M
- −$25.1M (−45.1%) vs. Q1 2022
- New holders
- 5
- 11 more added
- Sold out
- 11
- 19 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CLLS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 27 | $28.4M |
| Q1 2026 | 32 | $32.5M |
| Q4 2025 | 34 | $51.1M |
| Q3 2025 | 28 | $23.7M |
| Q2 2025 | 24 | $17.9M |
| Q1 2025 | 27 | $16.9M |
| Q4 2024 | 29 | $23.0M |
| Q3 2024 | 27 | $20.9M |
| Q2 2024 | 27 | $18.3M |
| Q1 2024 | 31 | $26.1M |
| Q4 2023 | 34 | $30.2M |
| Q3 2023 | 31 | $18.1M |
| Q2 2023 | 36 | $27.6M |
| Q1 2023 | 34 | $29.3M |
| Q4 2022 | 40 | $18.3M |
| Q3 2022 | 50 | $23.6M |
| Q2 2022 | 45 | $30.6M |
| Q1 2022 | 51 | $55.8M |
| Q4 2021 | 57 | $123.7M |
| Q3 2021 | 70 | $194.1M |
| Q2 2021 | 78 | $250.6M |
| Q1 2021 | 81 | $308.0M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Cellectis S.A.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| US Bancorp | 10 | $0 | 0.00% | −1,984−99.5% | Reduced |
| Parkside Financial Bank & Trust | 147 | $0 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 9 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 108 | $0 | 0.00% | +18+20.0% | Added |
| Daiwa Securities Group Inc. | 40 | $0 | 0.00% | 00.0% | Unchanged |
| Toronto Dominion Bank | 31 | $0 | 0.00% | +31 | New |
| BNP Paribas Arbitrage, SA | 229 | $648 | 0.00% | +229 | New |
| TD Waterhouse Canada Inc. | 360 | $954 | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 324 | $1.00K | 0.00% | −35,424−99.1% | Reduced |
| UBS Group AG | 394 | $1.00K | 0.00% | −2,374−85.8% | Reduced |
| Assetmark, Inc | 865 | $2.00K | 0.00% | +505+140.3% | Added |
| JPMorgan Chase & Co | 943 | $3.00K | 0.00% | −1,466−60.9% | Reduced |
| National Bank of Canada | 3,600 | $10.0K | 0.00% | +3,600 | New |
| Tower Research Capital LLC (TRC) | 6,363 | $18.0K | 0.00% | −1,886−22.9% | Reduced |
| Advisor Group Holdings, Inc. | 6,803 | $19.0K | 0.00% | −87−1.3% | Reduced |
| Princeton Capital Management LLC | 10,594 | $30.0K | 0.01% | −335−3.1% | Reduced |
| Geode Capital Management, LLC | 10,776 | $30.0K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 11,829 | $33.0K | 0.00% | −1,100−8.5% | Reduced |
| Vontobel Holding Ltd. | 14,000 | $40.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 15,300 | $43.0K | 0.00% | −39,500−72.1% | Reduced |
| Virtu Financial LLC | 16,366 | $46.0K | 0.00% | +16,366 | New |
| Envestnet Asset Management Inc | 20,939 | $59.0K | 0.00% | +438+2.1% | Added |
| Bank of America Corp | 21,816 | $61.0K | 0.00% | −21,799−50.0% | Reduced |
| Citadel Advisors LLC | 23,589 | $67.0K | 0.00% | +23,589 | New |
| WS Management LLLP | 50,907 | $144.0K | 0.02% | 00.0% | Unchanged |
| Oppenheimer & Co Inc | 75,633 | $214.0K | 0.00% | +979+1.3% | Added |
| Morgan Stanley | 99,951 | $283.0K | 0.00% | +17,541+21.3% | Added |
| Marshall Wace, LLP | 114,441 | $324.0K | 0.00% | −31,757−21.7% | Reduced |
| KBC Group NV | 163,447 | $463.0K | 0.00% | 00.0% | Unchanged |
| Mirae Asset Global Investments Co., Ltd. | 186,018 | $526.0K | 0.00% | +43,677+30.7% | Added |
| Macquarie Group Ltd | 226,875 | $642.0K | 0.00% | 00.0% | Unchanged |
| Capital World Investors | 250,000 | $708.0K | 0.00% | −371,065−59.7% | Reduced |
| State Street Corp | 253,725 | $718.0K | 0.00% | +134,164+112.2% | Added |
| D. E. Shaw & Co., Inc. | 271,549 | $768.0K | 0.00% | −28,138−9.4% | Reduced |
| Hudson Bay Capital Management LP | 275,000 | $778.0K | 0.01% | +63,500+30.0% | Added |
| BlackRock Inc. | 290,025 | $821.0K | 0.00% | −12,484−4.1% | Reduced |
| Bpifrance SA | 425,726 | $1.21M | 0.05% | 00.0% | Unchanged |
| Millennium Management LLC | 452,941 | $1.28M | 0.00% | +50,039+12.4% | Added |
| Jane Street Group, LLC | 490,230 | $1.36M | 0.00% | −113,023−18.7% | Reduced |
| Capital International Investors | 581,037 | $1.64M | 0.00% | −1,011,017−63.5% | Reduced |
| Baillie Gifford & Co | 880,932 | $2.49M | 0.00% | −201,163−18.6% | Reduced |
| Principal Financial Group Inc | 1,348,312 | $3.82M | 0.00% | +133,587+11.0% | Added |
| Credit Suisse AG | 1,438,255 | $4.07M | 0.00% | −3,330−0.2% | Reduced |
| Long Focus Capital Management, LLC | 2,791,610 | $7.90M | 1.59% | +249,251+9.8% | Added |
| Sofos Investments, Inc. | 12 | – | – | −8−40.0% | Reduced |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −131,848−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −53,223−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −38,455−100.0% | Sold out |
| Mitsubishi UFJ Kokusai Asset Management Co., Ltd. | 0 | $0 | 0.00% | −33,595−100.0% | Sold out |
| Vident Investment Advisory, LLC | 0 | $0 | 0.00% | −17,696−100.0% | Sold out |
| Old Mission Capital LLC | 0 | $0 | 0.00% | −17,068−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −2,500−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −1,036−100.0% | Sold out |
| Money Concepts Capital Corp | 0 | $0 | 0.00% | −515−100.0% | Sold out |
| TCWP LLC | 0 | $0 | 0.00% | −325−100.0% | Sold out |
| Koshinski Asset Management, Inc. | 0 | $0 | 0.00% | −200−100.0% | Sold out |